The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure (Q43818757)

27 November 2017

title

The effects of chronic carvedilol therapy on QT dispersion in patients with congestive heart failure (English)

1 reference

27 November 2017

1 reference

A Yildirir

1 reference

27 November 2017

E Sade

series ordinal

1 reference

27 November 2017

L Tokgozoglu

series ordinal

1 reference

27 November 2017

A Oto

series ordinal

1 reference

27 November 2017

publication date

1 December 2001

1 reference

European Journal of Heart Failure

27 November 2017

published in

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

page(s)

717-721

1 reference

Should asymptomatic ventricular arrhythmias in patients with congestive heart failure be treated with antiarrhythmic drugs?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Can drug effects on mortality in heart failure be predicted by any surrogate measure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Mechanism of ventricular arrhythmias caused by increased dispersion of repolarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Cellular electrophysiological changes during ischemia in isolated, coronary-perfused cat ventricle with healed myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Ramipril reduces QT dispersion in patients with acute myocardial infarction and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

QT dispersion and sudden unexpected death in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Congestive heart failure and arrhythmias: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Nonuniform recovery of excitability in the left ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Prognostic value of arrhythmogenic markers in systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Enalapril reduces QTc dispersion in mild congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Long-term beta-blocker therapy improves autonomic nervous regulation in advanced congestive heart failure: a longitudinal heart rate variability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

Effect of selective versus nonselective beta blockade on QT dispersion in patients with nonischemic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900191-X

10.1016/S1388-9842(01)00191-X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference